NEWARK, Del, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The in vitro diagnostics market is likely to thrive at an average CAGR of 4.8% between 2023 and 2033. The market is anticipated to cross a market share of US$ 129.9 billion by 2033 while it is valued at US$ 81.3 billion in 2023.
- Advanced medical science and complex diseases are fueling the demand for enhanced IVD tests. Furthermore, new healthcare awareness programs are pushing the agenda of better diagnostics for the finest treatment.
- Used for testing samples such as blood and saliva through concentration measuring and marker detection, in vitro diagnostic devices and solutions are anticipated to simplify diagnostic practices and shape them according to future health threats.
- Higher research and development along with the integration of the laboratory sector with diagnostic testing to aid public health is fueling the demand for in vitro diagnostic solutions.
- Advanced screening tools with enhanced efficiency and better digital monitoring are expected to make diagnostic procedures easy and smooth. Thus, the in vitro diagnostics market size is likely to expand during the forecast period.
- The growth of a common awareness around health and health risks is forcing people to keep a check on their health and optimize the latest tools for so.
- Microfluidic technologies are the leading sect that is expected to add significant advancements in in-vitro diagnostics solutions.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14381
Key Points
- The United States market leads the space in terms of market share. The market is expected to cross a value of US$ 51.9 billion by 2033. The regional market is expected to thrive at a CAGR of 4.4% between 2023 and 2033.
- The Indian in vitro diagnostics market leads in terms of CAGR. It thrives at a steady CAGR of 8.8% during the forecast period. The market is likely to reach a value of US$ 5.6 billion by 2033. Asian economies like India and China building their healthcare infrastructure by advancing them with the latest diagnostics solutions for early detection and faster prevention.
- Clinical chemistry is likely to thrive in the technology-type category as it covers massive diagnostic operations along with the prevention of life-threatening cancers. It is expected to thrive at a CAGR of 4.2% during the forecast period.
- The infectious disease segment tops the application category with a CAGR of 4.6% between 2023 and 2033. The growth is attributed to higher consumption.
Competitive Landscape
The key competitors focus on developing efficient, faster, and effective detection technology. Key competitors also merge, acquire, and partner with other companies to increase the supply chain and distribution channel. The key players in the market are: Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Abbott, Thermo Fisher Scientific
For Instance:
- Roche diagnostics has introduced its in vitro diagnostics (IVDs) that are to cover conditions and infections through blood tissue and urine. Furthermore, advanced diagnostic tools are launched by the company.
- Thermo Fisher Scientific has introduced its testing categories such as advanced instruments and automation technology, disease diagnostic, quality controls, and quality assurance software.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14381
Key Segments
By Product & Service:
- Reagents
- Instruments
- Services & Software
By Technology:
- Immunodiagnostics
- Hematology
- Molecular diagnostics
- Tissue diagnostics
- Clinical chemistry
- Others
By Application:
- Infectious diseases
- Cancer
- Cardiac diseases
- Immune system disorders
- Nephrological diseases
- Gastrointestinal diseases
- Others
By End User:
- Standalone laboratories
- Hospitals
- Academics & Medical Schools
- Point-of-Care
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific (APAC)
- The Middle East & Africa (MEA)
View Complete Report@ https://www.futuremarketinsights.com/reports/in-vitro-diagnostics-market
Table of Content
1. Executive Summary | In Vitro Diagnostics Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
Buy Now@ https://www.futuremarketinsights.com/checkout/14381
Have a Look at Related Reports of Healthcare domain
Keyhole Orthopaedic Surgery Market Size: The global keyhole orthopaedic surgery market is estimated to create an incremental opportunity of more than US$ 8 Billion by the end of 2032.
Cardiometabolic Drugs Market Share: The global cardiometabolic drugs market size reached US$ 50 Billion in 2021. The sales of cardiometabolic drugs are estimated to surpass a valuation of US$ 70 Billion by 2032, rising at a CAGR of 4% to 5% during the forecast period 2022 to 2032.
Assisted Walking Devices Market Demand: The market value of the global assisted walking devices market is anticipated to reach a high of US$ 6.33 billion by the year 2032.
Ocular Tuberculosis Therapeutics Market Overview: The global ocular tuberculosis therapeutics market is forecasted to be valued at US$ 753.2 million by 2032, up from US$ 405.0 million in 2022 and is advancing at a CAGR of 5.8% during the forecast period.
Non-invasive Brain Stimulation System Market Growth: According to Future Market Insight estimation, the non-invasive brain stimulation systems market will be worth US$1,200.5 million by 2022. To reach US$ 2,429.3 million by 2032, the market is anticipated to grow at a CAGR of 6.6% over the forecast period (2022 to 2032).
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, US, and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
